Renal Damage Inhibited in Mice Lacking Angiotensinogen Gene Subjected to Unilateral Ureteral Obstruction

Urology

Volumn 74, Issue 4, 2009, Pages 938-943

  Uchida, Yasumitsu ^a   Miyajima, Akira ^a   Kikuchi, Eiji ^a   Kozakai, Norihide ^a   Kosaka, Takeo ^a   Ieda, Masaki ^a   Fukuda, Keiichi ^a   Ohigashi, Takashi ^b   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; CD45 ANTIGEN; CYCLINE; SINGLE STRANDED DNA; TRANSFORMING GROWTH FACTOR BETA;

ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY INJURY; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; URETER OBSTRUCTION; WILD TYPE;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; FEMALE; FIBROSIS; KIDNEY DISEASES; MICE; MICE, INBRED C57BL; URETERAL OBSTRUCTION;

EID: 70349440752     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.059     Document Type: Article

References (27)

1. Klahr S., and Morrissey J.J. Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31 (1998) 171-176
2. Wolf G., Mueller E., Stahl R.A., et al. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92 (1993) 1366-1372
3. Wolf G. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanism. Nephrologie 19 (1998) 451-456
4. Ardaillou R., Chansel D., Chatziantoniou C., et al. Mesangial AT1 receptors: expression, signaling, and regulation. J Am Soc Nephrol 10 suppl 11 (1999) S40-S46
5. Miyajima A., Chen J., Lawrence C., et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58 (2000) 2301-2313
6. Morrissey J.J., Ishidoya S., McCracken R., et al. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7 (1996) 2202-2212
7. Eddy A.A. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5 (1994) 1273-1287
8. Risdon R.A., Sloper J.C., and De Wardener H.E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2 (1968) 363-366
9. Truong L.D., Petrusevska G., Yang G., et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50 (1996) 200-207
10. Ieda M., Fukuda K., Hisaka Y., et al. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 113 (2004) 876-884
11. Tanimoto K., Sugiyama F., Goto Y., et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269 (1994) 31334-31337
12. Gulmi F., Felsen D., and Vaughan E.J. Pathophysiology of urinary tract obstruction. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., et al. (Eds). Campbell's Urology. 8th ed. (2002), WB Saunders, Philadelphia 443-444
13. Klahr S., and Morrissey J.J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283 (2002) F861-F875
14. Ishidoya S., Morrissey J.J., McCracken R., et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47 (1995) 1285-1294
15. Morrissey J.J., and Klahr S. Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 276 (1999) F39-F45
16. Esteban V., Ruperez M., Vita J.R., et al. Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int Suppl 86 (2003) S33-S38
17. El Chaar M., Chen J., Seshan S.V., et al. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292 (2007) F1291-F1301
18. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway. Kidney Int 70 (2006) 1914-1919
19. Fern R.J., Yesko C.M., Thornhill B.A., et al. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103 (1999) 39-46
20. Brezniceanu M.L., Wei C.C., Zhang S.L., et al. Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells. Kidney Int 69 (2006) 1977-1985
21. Border W.A., Okuda S., Languino L., et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346 (1990) 371-374
22. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16 (1998) 137-161
23. 1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 35 (2000) 86-90
24. Ruiz-Ortega M., Ruperez M., Esteban V., et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21 (2006) 16-20
25. Miyajima A., Kosaka T., Seta K., et al. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169 (2003) 1559-1563
26. Miyajima A., Chen J., Kirman I., et al. Interaction of nitric oxide and transforming growth factor-β1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164 (2000) 1729-1734
27. Miyajima A., Chen J., Poppas D.P., et al. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59 (2001) 1290-1303